Published 4 February 2002. doi:10.1084/jem.20010934
© Rockefeller University Press, 0022-1007/2002/2/335/ $5.00
The Journal of Experimental Medicine, Volume 195, Number 3, February 4, 2002 335-341
Contact-dependent Stimulation and Inhibition of Dendritic Cells by Natural Killer Cells
Diego Piccioli,
Silverio Sbrana,
Emiliano Melandri and
Nicholas M. Valiante
IRIS, Department of Immunology, Chiron S.p.A., 53100 Siena, Italy
Address correspondence to N.M. Valiante, Immunology and Infectious Disease Research, Mail Stop 4.3, Chiron Corp., 4560 Horton St., Emeryville, CA 94608. Phone: 510-923-2964; Fax: 510-923-2586; E-mail: Nicholas_Valiante{at}Chiron.com
 |
Abstract
|
|---|
Natural killer (NK) cells and dendritic cells (DCs) are two distinct cell types of innate immunity. It is known that the in vitro interaction of human NK cells with autologous DCs results in DC lysis. Here we show that contact-dependent interactions between activated human NK cells and immature DCs (iDCs) provides a "control switch" for the immune system. At low NK/DC ratios, this interaction dramatically amplifies DC responses, whereas at high ratios it completely turns off their responses. Specifically, culture of activated human NK cells with iDCs, at low NK/DC ratios (1:5), led to exponential increases in DC cytokine production, which were completely dependent on cell-to-cell contact. DC maturation was also driven by cognate interactions with NK cells and maturation was dependent on endogenously produced TNF-
in the culture. At slightly higher NK/DC ratios (5:1), inhibition of DC functions was the dominant feature due to potent killing by the autologous NK cells. Resting NK cells also stimulated autologous DC maturation in a TNF-/contact-dependent manner, however, increasing the NK/DC ratio only led to an enhancement of this effect.
Key Words: NK cells • DCs • innate immunity • cytokines • CD86
|
Introduction
|
|---|
The innate immune response faces two mutually exclusive priorities. One is to respond to pathogenic threats with maximum speed and potency to initiate the immune response and mount the first line of defense against an infection. Competing with this goal is the requirement of controlling the initiation/amplification process to avoid overshoot and responses to benign stimuli. Failure to find a compromise between these two extremes can result in uncontrolled infection, for the former, or immune-mediated pathologies (e.g., septic shock or auto-immunity), for the latter. Cooperation between distinct immune cells and reciprocal coordination of their responses provides a robust mechanism for regulating the initiation and amplification of an immune response. NK cells and DCs are two specialized cell types of innate immunity and both act as liaisons between innate and antigen-specific responses (1, 2). DCs are considered sentinels of the immune system because of their role as initiators of both innate and antigen-specific immunity (1, 3). NK cells are lymphocytes active in innate responses against viruses, bacteria, and tumors, due to their potent cytotoxic activity and rapid production of cytokines (4). Although NK cells are part of innate immunity, they share many phenotypic and functional features with T cells (5–7). T cells cooperate with DCs in the initiation/amplification of antigen-specific responses (1, 3). We reasoned that NK cells may perform an analogous function during the initial phase of an immune response before activated T cells are generated. To address this hypothesis we developed an in vitro model to dissect the potential interactions between autologous NK cells and immature DCs (iDCs)* in the presence or absence of limiting concentrations of a bacterial stimulus (LPS). Using this culture system we have uncovered a new amplification/attenuation mechanism relevant to the regulation of innate immune responses in vivo.
|
Materials and Methods
|
|---|
Antibodies and Blocking Reagents.
Antibodies used for flow cytometry were: anti-CD86-FITC, -CD83-PE, -HLA-DR-PerCP, -CD69-FITC or -PE, -CD25-FITC, -CD3-FITC or -PE, -CD19-FITC, -CD14-FITC, -CD1a-FITC, -CD80-FITC or -PE, and -CD56-FITC or -PE (Becton Dickinson). Staining of cells was performed according to standard protocols and flow cytometric analysis was performed using a FACSCaliburTM cytometer. Antibodies used for magnetic activated cell sorting (MACS®) and subset purifications were: anti-CD3, anti-CD14, and anti-CD19 (Becton Dickinson). Blocking/neutralizing reagents used in different experiments were: anti–IFN- (mAb MMHA-1 and sheep polyclonal anti–human; Ancell); anti–IFN-ß (sheep polyclonal anti–human; Biosource International); r-hu-fas-ligand/Fc chimera (CD178; R&D Systems); hu-CTLA-4 muIg fusion protein (CD152; Ancell); anti–LFA-1 (CD11a, mAb G43–25B; Becton Dickinson); anti–TNF- (mAb B154.2); anti–IL-12 p40 (mAb C8.6); and anti–IFN-
(mAb B133.3) (all provided by G. Trinchieri, Schering Plough Corp., Lyon, France); humanized anti-CD40 (mAb 5H7; supplied by K. Chu, Chiron Corp., Emeryville, CA). All neutralizing antibodies and reagents were used at, at least, two different concentrations which were equal to and exceeded the manufacturers' instructions or their previously published levels for neutralization.
Cell Preparations and Cultures.
PBMCs were prepared from healthy blood donors (buffy coats or lab volunteers) by separation on a Ficoll-Hypaque gradient. iDCs were generated as described by Sallusto and Lanzavecchia (8). Briefly, highly purified (>98%) monocyte populations were obtained from PBMCs by MACS® (Miltenyi Biotec), using a one step positive selection of CD14+ cells with anti-CD14–coated magnetic microbeads (Miltenyi Biotec). The monocytes were then cultured for 5–6 d in RPMI 1640 medium (Life Technologies) supplemented with 10% FCS (Hyclone); IL-4 (10% of supernatant from an IL-4–secreting cell line, provided by A. Lanzavecchia, Institute for Research in Biomedicine, Bellinzona, Switzerland) and 50 ng/ml of GM-CSF (Leucomax®). After culture the iDC populations were routinely checked for CD1a and CD80 expression and their lack of CD14 expression. Purified (85–95% CD56+/CD3-), resting NK cells were obtained from PBMCs by MACS® (Miltenyi Biotec) using a two step protocol: PBMCs were first incubated with purified anti-CD3, anti-CD14, and anti-CD19 mAb's (Becton Dickinson) for 30 min followed by negative selection with goat anti–mouse microbeads (Miltenyi Biotec). After which the NK cells (which contained <1% contamination with CD3+, CD19+, and CD14+ cells but between 5–15% lineage negative cells) were frozen in 90% FCS; 10% DMSO for 5–6 d. Prior to their use in experiments with cultured, autologous iDCs, they were gently thawed, washed, and resuspended in RPMI 1640/10% FCS medium (RPMIc). Purified (99% CD56+/CD3-), activated NK cells were obtained using the method of Perussia et al. with slight modification (9). Briefly, PBMCs were cultured with the irradiated (5,000 rads) EBV-transformed B cell line, RPMI 8866, in 24-well plates at a ratio of 5:1 (PBMC:8866). For experiments with buffy coats the PBMCs were cultured for 5–6 d, whereas for PBMCs from lab volunteers who donated blood twice (first for NK cell cultures and then for iDC cultures), they were cultured for 8 d under the published conditions (9). After culture, purified NK cells were obtained by negative selection by MACS® (Miltenyi Biotec) as described above for resting NK cells.
NK–iDC Cultures.
The specific details of the different experiments are described in the figure legends. In general, activated/cultured or resting NK cells were added to autologous iDCs at the ratios (NK/DC) indicated and the cells were cocultured in RPMIc medium for 24–48 h in the presence or absence of the indicated doses of LPS (Sigma-Aldrich). Prior to coculture, the iDCs were removed from their GM-CSF/IL-4 containing medium by washing with RPMI 1640 medium. Control experiments comparing NK activation or iDC maturation in the presence or absence of the DC culture medium (GM-CSF/IL-4) showed no differences.
Measurement of Cytokine Production.
Cytokine production was quantified in culture supernatants by specific sandwich ELISA's for TNF- (capture/secondary; mAb's B154.9/B154.7), IL-12 p40 (mAb's C11.79/C8.6), and IL-10 (mAb's JES3–907/JES3–12G8). The antibodies for TNF- and IL-12 p40 ELISA were provided by G. Trinchieri and those for IL-10 were obtained from BD PharMingen. Recombinant standards for all assays were obtained from R&D Systems.
Cell-mediated Cytotoxicity Assays.
NK cell killing of iDCs or K562 was determined using standard 4-h chromium release assays and a flow cytometric assay for NK cell killing developed by McGinnes et al. with slight modifications (10). Briefly, iDCs or K562 cells were loaded with 5 µM CFDA SE for 5 or 15 min, respectively, and incubated in 96-well plates (U-bottom; Costar) with activated/cultured NK cells at the indicated NK/target ratios. After the indicated times (4 or 24 h) each sample was resuspended in a final volume of 600 µl of PBS, to which 50 µl of Flow Check fluorospheres (Beckman Coulter) were added. Using the cytometer, a fixed number (700) of fluorescent beads was acquired and the percentage of killing was calculated using the following equation: (the number of CFDA SE+ cells acquired in the control without NK cells) - (the number of CFDA SE+ cells in the sample)/(the sample of CFDA SE+ cells in the control) x 100. Comparison of 4-h chromium release assays with the 4-h flow cytometric procedure revealed minor differences with the flow cytometric technique being more sensitive (unpublished data).
NK Cell Conjugate Formation Assays.
NK–iDC or NK-K562 conjugates were detected by flow cytometry using NK cells labeled with CFDA SE (Molecular Probes) and iDCs or K562 labeled with SNARF-1 (Molecular Probes). After dye loading (NK cells and K562, 15 min at 37°C with 5 µM of CFDA SE or 2 µM SNARF-1, respectively, and iDCs, 5 min at 37°C with 2 µM of SNARF-1) the cells were washed and incubated alone or together (NK–K562 or NK–iDC) at the indicated ratios for 30 min at 37°C. Prior to incubation the cells were centrifuged at 200 g for 3 min at room temperature. The percentage of conjugates formed was calculated on a FACSCaliburTM cytometer (Becton Dickinson) by gating on the FL3+ cells (SNARF-1/iDCs or K562) and determining the percent of this population also positive for FL1 (CFDA SE/NK).
|
Results
|
|---|
Contact-dependent and Reciprocal Activation of NK Cells and iDCs.
We began our study by investigating the interactions between autologous iDCs and resting NK cells. These initial experiments demonstrated that both cell types become activated after coculture for 18–48 h. The iDCs showed evidence of maturation as determined by their increased expression of CD86 (Fig. 1 A), HLA-DR and CD83 (data not shown) which was augmented by the addition of increasing concentrations of LPS. The NK effect was dependent on cell-to-cell contact as separation of the cells by a permeable membrane (trans-well) completely abrogated DC maturation. Addition of a neutralizing antibody against TNF- also blocked NK-mediated maturation of the iDC (Fig. 1 B). By contrast, the addition of other blocking reagents specific for IL-12, IFN-, IFN-, IFN-ß, fas (CD95), ICAM-3 (CD50), CD40L (CD154), CD80, CD86, and LFA-1 (CD11a) to the cultures did not inhibit maturation (data not shown). Raising the NK/DC ratio consistently led to increased maturation of the DCs (Fig. 1 C).
Under the same conditions, NK cells were also stimulated by the iDCs and upregulated their expression of the activation markers CD69 (Fig. 1 D) and CD25 (data not shown), however, the addition of LPS to the cultures did not enhance this activation. Unlike DC maturation, increasing the NK/DC ratio in favor of the NK cells led to decreased expression of these activation markers, and at the highest NK/DC ratios tested, the expression of CD69 returned to baseline. The activation of NK cells observed in these cultures was dependent on contact with the iDCs (Fig. 1 E–G). The blocking reagents used in the previous experiments on DC maturation also had no effect on iDC-mediated NK cell activation, and neither did a neutralizing antibody to TNF- (data not shown). Thus, contact-dependent interactions between NK cells and iDCs could provide a novel positive feedback loop for the innate immune response which is reciprocally regulated by the number of NK–DC encounters.
Stimulation/Inhibition of iDC Functions by Activated NK Cells.
Two previous studies have shown that both resting and activated NK cells partially kill autologous DCs, as measured by 3–4-h chromium release assays using high NK/DC ratios (11, 12). However, in our long-term cultures (24–48 h) the NK cells stimulated the iDCs rather than lysing them. Based on these conflicting results, we examined in more detail the apparent stimulation of iDCs after contact with NK cells. We reasoned that activated NK cells would be more useful for these experiments because (i) an encounter in vivo between NK cells that normally traffic in the blood (4) and iDCs which reside in the tissues (1, 3), should only occur when both cells are activated; (ii) activated NK cells mediate more potent lysis of iDCs (11–13), thereby allowing for a more rigorous examination of a potential cytotoxic effect; and (iii) the number of NK cells obtained after short-term in vitro culture would be far greater providing more cells for analysis (9).
The DC maturation induced by resting NK cells we observed was dependent on endogenous TNF- production. Furthermore, TNF- and other proinflammatory cytokines are important amplifiers of immune responses (14). Therefore, we used TNF- production as a readout for DC stimulation in our culture system. Culturing activated NK cells with DCs at low NK/DC ratios (1:5) led to increases in TNF- production, which were augmented dramatically by the addition of suboptimal doses (10 ng/ml) of LPS (Fig. 2 A). The increased TNF- production was dependent on cell-to-cell contact because when the two cell types were separated in trans-wells, no stimulation was observed (Fig. 2 B). In separate experiments we observed this NK-stimulatory effect on TNF- production at NK/DC ratios as low as 1:20 and 1:40 (data not shown). Raising the NK/DC ratio to 5:1 changes the interaction from one of potent DC stimulation to that of complete inhibition in the presence or absence of LPS (Fig. 2 C). An identical pattern is seen for IL-12 p40 production (Fig. 2 D). No IL-10 production in the cultures was detected under any of the conditions tested (data not shown). The massive production of TNF- in the cultures at the lowest ratios was mediated primarily by DCs in the culture due to the low number of NK cells (2 x 104 cells per well) used in these experiments. In addition, efforts to stimulate NK cells directly with optimal doses of anti-CD16, rIL-2, rIL-12, and PMA/ionomycin alone or in combination induced only moderate (<500 pg/ml) TNF- production by the NK cells alone which were present at 2 x 105 cells per well (data not shown).
Blocking reagents for CD80, CD86, CD154, CD95, CD11a, CD50, or IL-12, had no effect on the NK cell–induced TNF- or IL-12 p40 production, whereas a neutralizing antibody for IFN- while not affecting TNF- production partially blocked (<20%) IL-12 p40 production induced by the NK cells (Fig. 2 E). This partial inhibition is consistent with numerous previous reports demonstrating a central role for an IL-12/IFN- positive feedback loop active between NK cells and IL-12–producing cells (15–17). Clearly, however, this well-described cytokine cross-talk mechanism is secondary to the contact-dependent activation of DCs by NK cells described here. Taken together these results indicate that novel mechanisms control cognate interactions between NK cells and DCs and that NK–DC contact has the potential to serve as an important control switch for both amplifying and attenuating innate immune responses in vivo.
We next tested directly whether NK cell killing was active in our system using both short-term (4-h) chromium release assays (data not shown) and a flow cytometric assay which allowed us to follow the survival of the autologous iDCs in the presence of NK cells over longer periods (Fig. 3). The results demonstrate that NK cells kill autologous iDCs (Fig. 3 A) at all NK/DC ratios tested after 4 h and the level of killing is similar to the lysis of K562 cells over the same time (Fig. 3 B). After 24 h, however, the presence of NK cells led to completely divergent effects on the DCs. At the 5:1 (NK/DC) ratio, NK cell–mediated destruction of the iDCs was the dominant feature, whereas at the low ratio (1:5) the same NK cells promoted iDCs survival compared with iDCs alone over the same period (Fig. 3 A). The equal ratio of NK/DC (1:1) fell between these two extremes. The NK cell–mediated lysis of the K562 targets increased at all ratios tested after the 24-h incubation. These striking differences between death and survival of DCs upon encountering NK cells correlate precisely with our previous results on TNF- and IL-12 p40 production where increasing numbers of NK cells in the culture shifts the NK effect from potent stimulation to complete inhibition (Fig. 2).
NK cells can both efficiently kill and potently stimulate DCs in our model system and each of these opposing effects appear dependent on cell-to-cell contact. To quantify these apparent cognate interactions we measured the formation of NK–DC conjugates and compared them to conjugates formed by NK cells and tumor targets. Our analysis revealed that NK cells bound DC (Fig. 3 C–E) with an efficiency almost equal to that of NK cell binding to the classical NK-target, K562 (Fig. 3 F–H). Binding was detectable even at the lowest NK/DC ratio tested (1:5) indicating that NK–DC conjugates are formed in our other experiments measuring cytokine production and cell killing.
Our initial experiments using resting NK cells (Fig. 1) demonstrated a contact-dependent NK effect driving iDCs to mature. Therefore, we tested what effects activated NK cells mediated on DC maturation (Fig. 4). Similar to our previous results with activated NK cells (Figs. 2 and 3), addition of NK cells to the culture leads to opposing effects on the iDC population depending on the NK/DC ratio. Compared with the untreated DCs (Fig. 4 A–C), low NK/DC ratios (1:5 or 1:1) consistently augmented expression of the maturation markers: CD86 (Fig. 4 D–I), CD83, and HLA-DR (data not shown). At a 5:1 ratio (NK/DC) most of the DCs are nonviable (Fig. 4 J–L). Addition of suboptimal doses of LPS (Fig. 4 C, F, I, and L) augmented the NK-induced maturation at NK/DC ratios of 1:5 and 1:1, but had no effect at the 5:1 ratio. Again, DC maturation was dependent on NK cell contact and endogenously produced TNF-, because it did not occur when the two cell types were separated in trans-wells or upon the addition of a neutralizing antibody for TNF- (Fig. 5). Moreover, addition of blocking reagents for CD80, CD86, CD154, CD95, CD11a, CD50, IL-12, IFN-, IFN-, or IFN-ß had no effect on the NK-induced maturation (data not shown).
View larger version (57K):
[in this window]
[in a new window]
|
Figure 4. Activated/cultured NK cell–mediated maturation/death of DCs. Cultured iDCs were incubated for 48 h, alone (A–C), or with NK cells at the following ratios (NK/DC), 1:5 (D–F), 1:1 (G–I), and 5:1 (J–L). Forward versus side scatter plots (A, D, G, and J) show the gating on the DC subset and demonstrate its disappearance at the 5:1 (NK/DC) ratio (J). Propidium iodide staining of the NK/DC (5:1) cultures confirmed the almost complete absence of viable DCs (data not shown). Staining for CD86 expression was performed as described in Fig. 1 and the histograms are shown for DCs cultured in the presence (C, F, I, and L) or absence (B, E, H, and K) of 1 ng/ml of LPS. Results are representative of six experiments performed.
| |
|
Discussion
|
|---|
Cognate interactions are a common feature of the antigen-specific immune response, where intimate cell-to-cell contact governs such critical events as antigen presentation, and the delivery of T cell help to CTLs and B cells (1, 3, 18–20). By contrast, coordinated control of innate immunity is thought to be mediated almost exclusively by cytokine feedback loops (2, 17, 21). Recently, one exception to this general rule has been proposed for the innate immune system and importantly, it involves contact-dependent activation of murine NK cells by iDCs (22). Consistent with this study, we also see evidence of NK cell activation in our system which is dependent on DC contact, although we have not investigated the extent and nature of this NK activation in further detail.
NK cells arrive at sites of infection within minutes to hours after pathogen invasion (4, 21, 23). Here, they should encounter resident DCs already responding to signals derived from invading pathogens and proinflammatory cytokines such as TNF- (1, 3). We designed our in vitro model to recapitulate some of the most salient features of the early inflammatory process. This simple model cannot reproduce many aspects of the in vivo situation where the flow of immune cells, pathogens, and soluble factors in and out of the inflamed tissue is a dynamic process. Nevertheless, using this system, we have defined two extreme outcomes of an NK–DC encounter: (i) potent amplification and (ii) complete inhibition. During a normal functioning immune response, the majority of in vivo relevance of this NK–DC "control switch" likely lies at various points between the two in vitro extremes described here. However, it is tempting to speculate that the dramatic NK-mediated stimulation/inhibition of TNF- production we observe reveals a novel positive/negative feedback loop applicable to TNF-–mediated pathologies such as septic shock.
The inhibition of DC responses by NK cells at high NK/DC ratios, appears simply due to NK cell–mediated cytotoxicity which has already been described as a potential outcome of NK–DC encounters (11, 12). However, with the exception of endogenous TNF- production which is necessary for NK-induced DC maturation, all other experiments using blocking reagents against numerous surface receptors and soluble factors failed to reveal a specific mechanism for the NK cell stimulatory effect. Although we cannot rule out the possibility that untested receptor/ligand pairs govern this interaction, we propose an alternative model founded on the more general phenomenon of NK cell killing of DCs. The model is based on the hypothesis that the majority of NK–DC interactions are fatal for the DCs. Thus, amplification of DC responses occurs by a bystander effect whereby killing of DCs by NK cells provides the activation signal(s) for their nonNK-binding neighbors. At low NK/DC ratios there are plenty of viable DCs to mediate this bystander effect, whereas, at higher ratios, there are no bystanders. This model fits nicely with our current understanding of the heterogeneous nature of NK cell triggering receptors (24) and is consistent with the results presented here. Moreover, it adds a new twist to "Stranger/Danger" models (25–28) for the initiation/amplification of innate immune responses. Thus, the arrival of activated NK cells ("stranger") into infected tissues and their killing ("danger") of resident DCs serves to amplify the "stranger/danger" signals derived from invading pathogens. It will be important to test this model with particular emphasis placed on understanding a role (or lack thereof) for NK cell inhibitory/stimulatory receptors for autologous HLA class I molecules (24). Given the exquisite sensitivity of autologous iDCs (11, 12) to NK cell cytotoxicity, it is likely that during an NK–DC encounter the diverse families of NK cell receptors for class I function differently than they do during encounters with more traditional target cell types.
|
Acknowledgments
|
|---|
We wish to thank Rino Rappuoli, Giuseppe Del Giudice, and Antonio Lanzavecchia for stimulating discussions and their critical reading of the manuscript. A special thanks to our volunteer blood donors because without their generosity and patience many of these studies would not have been possible.
Submitted: June 4, 2001
Revised: October 25, 2001
Accepted: December 10, 2001
|
Footnotes
|
|---|
S. Sbrana's present address is Istituto di Fisiologia Clinica CNR Ospedale Pediatrico Apuano, G. Pasquinucci Via Aurelia Sud, 54100 Massa, Italy.
* Abbreviation used in this paper: iDC, immature DC. 
|
References
|
|---|
1
Banchereau, J., and R. Steinman. 1998. Dendritic cells and the control of immunity. Nature. 392:245–252.[CrossRef][Medline]
2
Scott, P., and G. Trinchieri. 1995. The role of natural killer cells in host-parasite interactions. Curr. Opin. Immunol. 7:34–40.[CrossRef][Medline]
3
Cella, M., F. Sallusto, and A. Lanzavecchia. 1997. Origin, maturation and antigen presenting function of dendritic cells. Curr. Opin. Immunol. 9:10–16.[CrossRef][Medline]
4
Trinchieri, G. 1989. Biology of natural killer cells. Adv. Immunol. 47:187–376.[Medline]
5
Sanchez, M.J., M.O. Muench, M.G. Roncarolo, L.L. Lanier, and J.H. Phillips. 1994. Identification of a common T/natural killer cell progenitor in human fetal thymus. J. Exp. Med. 180:569–576.[Abstract/Free Full Text]
6
Lanier, L.L., H. Spits, and J.H. Phillips. 1992. The developmental relationship between NK cells and T cells. Immunol. Today. 13:392–395.[CrossRef][Medline]
7
Valiante, N.M., and P. Parham. 1996. NK cells and CTL: opposite sides of the same coin. Chem. Immunol. 64:146–163.[Medline]
8
Sallusto, F., and A. Lanzavecchia. 1994. Efficient presentation of soluble antigen by cultured human dendritic cells is maintained by granulocyte/macrophage colony-stimulating factor plus interleukin 4 and downregulated by tumor necrosis factor . J. Exp. Med. 179:1109–1118.[Abstract/Free Full Text]
9
Perussia, B., C. Ramoni, I. Anegon, M.C. Cuturi, J. Faust, and G. Trinchieri. 1987. Preferential proliferation of natural killer cells among perpheral blood mononuclear cells co-cultured with B lymphoblastoid cell lines. Nat. Immun. Cell Growth Reg. 6:171–182.[Medline]
10
McGinnes, K., G. Chapman, R. Marks, and R. Penny. 1986. A fluorescence NK assay using flow cytometry. J. Immunol. Methods. 86:7–15.[CrossRef][Medline]
11
Carbone, E., G. Terrazzano, G. Ruggiero, D. Zanzi, A. Ottaiano, C. Manzo, K. Karre, and S. Zappacosta. 1999. Recognition of autologous dendritic cells by human NK cells. Eur. J. Immunol. 29:4022–4029.[CrossRef][Medline]
12
Wilson, J., L. Heffler, J. Charo, A. Scheynius, M. Bejarano, and H. Ljunggren. 1999. Targeting of human dendritic cells by autologous NK cells. J. Immunol. 1999. 163:6365–6370.
13
Phillips, J.H., and L.L. Lanier. 1986. Dissection of the lymphokine-activated killer phenomenon. J. Exp. Med. 164:814–825.[Abstract/Free Full Text]
14
Tracey, K., and A. Cerami. 1994. Tumor necrosis factor: a pleiotropic cytokine and therapeutic target. Annu. Rev. Med. 45:491–503.[CrossRef][Medline]
15
Scharton, T.M., and P. Scott. 1993. Natural killer cells are a source of IFN- that drives differentiation of CD4+ T cell subsets and induces resistance to Leishmania major of mice. J. Exp. Med. 178:567–577.[Abstract/Free Full Text]
16
Scott, P. 1993. IL-12: initiation cytokine for cell-mediated immunity. Science. 260:496–497.[Free Full Text]
17
Trinchieri, G. 1997. Cytokines acting on or secreted by macrophages during intracellular infection (IL-10, IL-12, IFN-). Curr. Opin. Immunol. 9:17–23.[CrossRef][Medline]
18
Davis, M.M., and P.J. Bjorkman. 1988. T-cell antigen receptor genes and T-cell recognition. Nature. 334:395–402.[CrossRef][Medline]
19
Scherle, P., and W. Gerhard. 1986. Functional analysis of influenza-specific helper T cell clones in vivo. T cells specific for internal viral proteins provide cognate help for B cell responses to hemagglutinin. J. Exp. Med. 164:1114–1128.[Abstract/Free Full Text]
20
Krowka, J., B. Singh, A. Fotedar, T. Mossman, M. Giedlin, and L. Pilarski. 1986. A requirement for physical linkage between determinants recognized by helper molecules and cytotoxic T cell precursors in the induction of cytotoxic T cell responses. J. Immunol. 136:3561–3566.[Abstract]
21
Unanue, E.R. 1997. Inter-relationship among macrophages, natural killer cells and neutrophils in early stages of Listeria resistance. Curr. Opin. Immunol. 9:35–43.[CrossRef][Medline]
22
Fernandez, N., A. Lozier, C. Flament, P. Ricciardi-Castagnoli, D. Bellet, M. Suter, M. Perricaudet, T. Tursz, E. Maraskovsky, and L. Zitvogel. 1999. Dendritic cells directly trigger NK cell functions: cross-talk relevant in innate anti-tumor immune responses in vivo. Nat. Med. 5:405–411.[CrossRef][Medline]
23
Scharton-Kersten, T.M., and A. Sher. 1997. Role of natural killer cells in innate resistance to protozoan infections. Curr. Opin. Immunol. 9:44–51.[CrossRef][Medline]
24
Lanier, L.L. 1998. NK cell receptors. Annu. Rev. Immunol. 16:359–393.[CrossRef][Medline]
25
Janeway, C.J., C. Goodnow, and R. Medzhitov. 1996. Danger-pathogen on the premises! Immunological tolerance. Curr. Biol. 6:519–522.[CrossRef][Medline]
26
Vance, R. 2000. A Copernican Revolution? Doubts about the danger theory. J. Immunol. 165:1725–1728.[Abstract/Free Full Text]
27
Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991–1045.[Medline]
28
Ridge, J., E. Fuchs, and P. Matzinger. 1996. Neonatal tolerance revisited: turning on newborn T cells with dendritic cells. Science. 271:1723–1726.[Abstract]
CiteULike 
Complore 
Connotea 
Del.icio.us 
Digg 
Reddit 
Technorati What's this?
This article has been cited by other articles:
-
Morandi, B., Mortara, L., Carrega, P., Cantoni, C., Costa, G., Accolla, R. S., Mingari, M. C., Ferrini, S., Moretta, L., Ferlazzo, G.
(2009). NK cells provide helper signal for CD8+ T cells by inducing the expression of membrane-bound IL-15 on DCs. Int Immunol
21: 599-606
[Abstract]
[Full Text]
-
Ko, H.-J., Lee, J.-M., Kim, Y.-J., Kim, Y.-S., Lee, K.-A, Kang, C.-Y.
(2009). Immunosuppressive Myeloid-Derived Suppressor Cells Can Be Converted into Immunogenic APCs with the Help of Activated NKT Cells: An Alternative Cell-Based Antitumor Vaccine. J. Immunol.
182: 1818-1828
[Abstract]
[Full Text]
-
Ing, R., Stevenson, M. M.
(2009). Dendritic Cell and NK Cell Reciprocal Cross Talk Promotes Gamma Interferon-Dependent Immunity to Blood-Stage Plasmodium chabaudi AS Infection in Mice. Infect. Immun.
77: 770-782
[Abstract]
[Full Text]
-
Wu, J. A., Johnson, B. L., Chen, Y., Ha, C. T., Dveksler, G. S.
(2008). Murine Pregnancy-Specific Glycoprotein 23 Induces the Proangiogenic Factors Transforming-Growth Factor Beta 1 and Vascular Endothelial Growth Factor A in Cell Types Involved in Vascular Remodeling in Pregnancy. Biol. Reprod.
79: 1054-1061
[Abstract]
[Full Text]
-
Nausch, N., Galani, I. E., Schlecker, E., Cerwenka, A.
(2008). Mononuclear myeloid-derived "suppressor" cells express RAE-1 and activate natural killer cells. Blood
112: 4080-4089
[Abstract]
[Full Text]
-
Watt, S. V., Andrews, D. M., Takeda, K., Smyth, M. J., Hayakawa, Y.
(2008). IFN-{gamma}-Dependent Recruitment of Mature CD27high NK Cells to Lymph Nodes Primed by Dendritic Cells. J. Immunol.
181: 5323-5330
[Abstract]
[Full Text]
-
Behrends, J., Karsten, C. M., Wilke, S., Robke, A., Kruse, A.
(2008). Identification of ITGA4/ITGB7 and ITGAE/ITGB7 Expressing Subsets of Decidual Dendritic-Like Cells Within Distinct Microdomains of the Pregnant Mouse Uterus. Biol. Reprod.
79: 624-632
[Abstract]
[Full Text]
-
Marcenaro, E., Ferranti, B., Falco, M., Moretta, L., Moretta, A.
(2008). Human NK cells directly recognize Mycobacterium bovis via TLR2 and acquire the ability to kill monocyte-derived DC. Int Immunol
20: 1155-1167
[Abstract]
[Full Text]
-
Agaugue, S., Marcenaro, E., Ferranti, B., Moretta, L., Moretta, A.
(2008). Human natural killer cells exposed to IL-2, IL-12, IL-18, or IL-4 differently modulate priming of naive T cells by monocyte-derived dendritic cells. Blood
112: 1776-1783
[Abstract]
[Full Text]
-
Strowig, T., Brilot, F., Munz, C.
(2008). Noncytotoxic Functions of NK Cells: Direct Pathogen Restriction and Assistance to Adaptive Immunity. J. Immunol.
180: 7785-7791
[Abstract]
[Full Text]
-
Binyamin, L., Alpaugh, R. K., Hughes, T. L., Lutz, C. T., Campbell, K. S., Weiner, L. M.
(2008). Blocking NK Cell Inhibitory Self-Recognition Promotes Antibody-Dependent Cellular Cytotoxicity in a Model of Anti-Lymphoma Therapy. J. Immunol.
180: 6392-6401
[Abstract]
[Full Text]
-
Terme, M., Chaput, N., Combadiere, B., Ma, A., Ohteki, T., Zitvogel, L.
(2008). Regulatory T Cells Control Dendritic Cell/NK Cell Cross-Talk in Lymph Nodes at the Steady State by Inhibiting CD4+ Self-Reactive T Cells. J. Immunol.
180: 4679-4686
[Abstract]
[Full Text]
-
Pilbeam, K., Basse, P., Brossay, L., Vujanovic, N., Gerstein, R., Vallejo, A. N., Borghesi, L.
(2008). The Ontogeny and Fate of NK Cells Marked by Permanent DNA Rearrangements. J. Immunol.
180: 1432-1441
[Abstract]
[Full Text]
-
Papewalis, C., Jacobs, B., Wuttke, M., Ullrich, E., Baehring, T., Fenk, R., Willenberg, H. S., Schinner, S., Cohnen, M., Seissler, J., Zacharowski, K., Scherbaum, W. A., Schott, M.
(2008). IFN-{alpha} Skews Monocytes into CD56+-Expressing Dendritic Cells with Potent Functional Activities In Vitro and In Vivo. J. Immunol.
180: 1462-1470
[Abstract]
[Full Text]
-
Fink, L. N., Zeuthen, L. H., Christensen, H. R., Morandi, B., Frokiaer, H., Ferlazzo, G.
(2007). Distinct gut-derived lactic acid bacteria elicit divergent dendritic cell-mediated NK cell responses. Int Immunol
19: 1319-1327
[Abstract]
[Full Text]
-
Schierloh, P., Yokobori, N., Aleman, M., Landoni, V., Geffner, L., Musella, R. M., Castagnino, J., Baldini, M., Abbate, E., de la Barrera, S. S., Sasiain, M. C.
(2007). Mycobacterium tuberculosis-Induced Gamma Interferon Production by Natural Killer Cells Requires Cross Talk with Antigen-Presenting Cells Involving Toll-Like Receptors 2 and 4 and the Mannose Receptor in Tuberculous Pleurisy. Infect. Immun.
75: 5325-5337
[Abstract]
[Full Text]
-
Tha-In, T., Metselaar, H. J., Tilanus, H. W., Groothuismink, Z. M. A., Kuipers, E. J., de Man, R. A., Kwekkeboom, J.
(2007). Intravenous immunoglobulins suppress T-cell priming by modulating the bidirectional interaction between dendritic cells and natural killer cells. Blood
110: 3253-3262
[Abstract]
[Full Text]
-
Vosshenrich, C. A.J., Lesjean-Pottier, S., Hasan, M., Richard-Le Goff, O., Corcuff, E., Mandelboim, O., Di Santo, J. P.
(2007). CD11cloB220+ interferon-producing killer dendritic cells are activated natural killer cells. JEM
204: 2569-2578
[Abstract]
[Full Text]
-
Giroux, M., Yurchenko, E., St.-Pierre, J., Piccirillo, C. A., Perreault, C.
(2007). T Regulatory Cells Control Numbers of NK Cells and CD8{alpha}+ Immature Dendritic Cells in the Lymph Node Paracortex. J. Immunol.
179: 4492-4502
[Abstract]
[Full Text]
-
Galazka, G., Jurewicz, A., Orlowski, W., Stasiolek, M., Brosnan, C. F., Raine, C. S., Selmaj, K.
(2007). EAE Tolerance Induction with Hsp70-Peptide Complexes Depends on H60 and NKG2D Activity. J. Immunol.
179: 4503-4512
[Abstract]
[Full Text]
-
Colmenero, P., Zhang, A. L., Qian, T., Lu, L., Cantor, H., Soderstrom, K., Engleman, E. G.
(2007). Qa-1b-Dependent Modulation of Dendritic Cell and NK Cell Cross-Talk In Vivo. J. Immunol.
179: 4608-4615
[Abstract]
[Full Text]
-
Blois, S. M, Kammerer, U., Soto, C. A., Tometten, M. C, Shaikly, V., Barrientos, G., Jurd, R., Rukavina, D., Thomson, A. W, Klapp, B. F, Fernandez, N., Arck, P. C
(2007). Dendritic Cells: Key to Fetal Tolerance?. Biol. Reprod.
77: 590-598
[Abstract]
[Full Text]
-
Zhang, A. L., Colmenero, P., Purath, U., Teixeira de Matos, C., Hueber, W., Klareskog, L., Tarner, I. H., Engleman, E. G., Soderstrom, K.
(2007). Natural killer cells trigger differentiation of monocytes into dendritic cells. Blood
110: 2484-2493
[Abstract]
[Full Text]
-
Thoren, F. B., Betten, A., Romero, A. I., Hellstrand, K.
(2007). Cutting Edge: Antioxidative Properties of Myeloid Dendritic Cells: Protection of T Cells and NK Cells from Oxygen Radical-Induced Inactivation and Apoptosis. J. Immunol.
179: 21-25
[Abstract]
[Full Text]
-
Guan, H., Moretto, M., Bzik, D. J., Gigley, J., Khan, I. A.
(2007). NK Cells Enhance Dendritic Cell Response against Parasite Antigens via NKG2D Pathway. J. Immunol.
179: 590-596
[Abstract]
[Full Text]
-
Barber, M. A., Zhang, T., Gagne, B. A., Sentman, C. L.
(2007). NK Cells Negatively Regulate Antigen Presentation and Tumor-Specific CTLs in a Syngeneic Lymphoma Model. J. Immunol.
178: 6140-6147
[Abstract]
[Full Text]
-
Parolini, S., Santoro, A., Marcenaro, E., Luini, W., Massardi, L., Facchetti, F., Communi, D., Parmentier, M., Majorana, A., Sironi, M., Tabellini, G., Moretta, A., Sozzani, S.
(2007). The role of chemerin in the colocalization of NK and dendritic cell subsets into inflamed tissues. Blood
109: 3625-3632
[Abstract]
[Full Text]
-
Xu, J., Chakrabarti, A. K., Tan, J. L., Ge, L., Gambotto, A., Vujanovic, N. L.
(2007). Essential role of the TNF-TNFR2 cognate interaction in mouse dendritic cell-natural killer cell crosstalk. Blood
109: 3333-3341
[Abstract]
[Full Text]
-
Draghi, M., Pashine, A., Sanjanwala, B., Gendzekhadze, K., Cantoni, C., Cosman, D., Moretta, A., Valiante, N. M., Parham, P.
(2007). NKp46 and NKG2D Recognition of Infected Dendritic Cells Is Necessary for NK Cell Activation in the Human Response to Influenza Infection. J. Immunol.
178: 2688-2698
[Abstract]
[Full Text]
-
Houtenbos, I., Westers, T. M., Dijkhuis, A., de Gruijl, T. D., Ossenkoppele, G. J., van de Loosdrecht, A. A.
(2007). Leukemia-Specific T-Cell Reactivity Induced by Leukemic Dendritic Cells Is Augmented by 4-1BB Targeting. Clin. Cancer Res.
13: 307-315
[Abstract]
[Full Text]
-
Chiesa, M. D., Carlomagno, S., Frumento, G., Balsamo, M., Cantoni, C., Conte, R., Moretta, L., Moretta, A., Vitale, M.
(2006). The tryptophan catabolite L-kynurenine inhibits the surface expression of NKp46- and NKG2D-activating receptors and regulates NK-cell function. Blood
108: 4118-4125
[Abstract]
[Full Text]
-
He, X.-S., Holmes, T. H., Zhang, C., Mahmood, K., Kemble, G. W., Lewis, D. B., Dekker, C. L., Greenberg, H. B., Arvin, A. M.
(2006). Cellular Immune Responses in Children and Adults Receiving Inactivated or Live Attenuated Influenza Vaccines. J. Virol.
80: 11756-11766
[Abstract]
[Full Text]
-
Chiesa, M. D., Romagnani, C., Thiel, A., Moretta, L., Moretta, A.
(2006). Multidirectional interactions are bridging human NK cells with plasmacytoid and monocyte-derived dendritic cells during innate immune responses. Blood
108: 3851-3858
[Abstract]
[Full Text]
-
Mavilio, D., Lombardo, G., Kinter, A., Fogli, M., La Sala, A., Ortolano, S., Farschi, A., Follmann, D., Gregg, R., Kovacs, C., Marcenaro, E., Pende, D., Moretta, A., Fauci, A. S.
(2006). Characterization of the defective interaction between a subset of natural killer cells and dendritic cells in HIV-1 infection. JEM
203: 2339-2350
[Abstract]
[Full Text]
-
McGrath-Morrow, S., Laube, B., Tzou, S.-C., Cho, C., Cleary, J., Kimura, H., Rose, N. R., Caturegli, P.
(2006). IL-12 overexpression in mice as a model for Sjogren lung disease. Am. J. Physiol. Lung Cell. Mol. Physiol.
291: L837-L846
[Abstract]
[Full Text]
-
Hanabuchi, S., Watanabe, N., Wang, Y.-H., Wang, Y.-H., Ito, T., Shaw, J., Cao, W., Qin, F. X.-F., Liu, Y.-J.
(2006). Human plasmacytoid predendritic cells activate NK cells through glucocorticoid-induced tumor necrosis factor receptor-ligand (GITRL). Blood
107: 3617-3623
[Abstract]
[Full Text]
-
Ebata, K., Shimizu, Y., Nakayama, Y., Minemura, M., Murakami, J., Kato, T., Yasumura, S., Takahara, T., Sugiyama, T., Saito, S.
(2006). Immature NK Cells Suppress Dendritic Cell Functions during the Development of Leukemia in a Mouse Model. J. Immunol.
176: 4113-4124
[Abstract]
[Full Text]
-
Bajenoff, M., Breart, B., Huang, A. Y.C., Qi, H., Cazareth, J., Braud, V. M., Germain, R. N., Glaichenhaus, N.
(2006). Natural killer cell behavior in lymph nodes revealed by static and real-time imaging. JEM
203: 619-631
[Abstract]
[Full Text]
-
Brooks, C. R., Elliott, T., Parham, P., Khakoo, S. I.
(2006). The Inhibitory Receptor NKG2A Determines Lysis of Vaccinia Virus-Infected Autologous Targets by NK Cells. J. Immunol.
176: 1141-1147
[Abstract]
[Full Text]
-
Dao, T., Gomez-Nunez, M., Antczak, C., Kappel, B., Singh Jaggi, J., Korontsvit, T., Zakhaleva, V., Scheinberg, D. A.
(2005). Natural Killer Cells License Dendritic Cell Cross-Presentation of B Lymphoma Cell-Associated Antigens. Clin. Cancer Res.
11: 8763-8772
[Abstract]
[Full Text]
-
Lutskiy, M. I., Beardsley, D. S., Rosen, F. S., Remold-O'Donnell, E.
(2005). Mosaicism of NK cells in a patient with Wiskott-Aldrich syndrome. Blood
106: 2815-2817
[Abstract]
[Full Text]
-
Mailliard, R. B., Alber, S. M., Shen, H., Watkins, S. C., Kirkwood, J. M., Herberman, R. B., Kalinski, P.
(2005). IL-18-induced CD83+CCR7+ NK helper cells. JEM
202: 941-953
[Abstract]
[Full Text]
-
Meier, U.-C., Owen, R. E., Taylor, E., Worth, A., Naoumov, N., Willberg, C., Tang, K., Newton, P., Pellegrino, P., Williams, I., Klenerman, P., Borrow, P.
(2005). Shared Alterations in NK Cell Frequency, Phenotype, and Function in Chronic Human Immunodeficiency Virus and Hepatitis C Virus Infections. J. Virol.
79: 12365-12374
[Abstract]
[Full Text]
-
Walzer, T., Dalod, M., Robbins, S. H., Zitvogel, L., Vivier, E.
(2005). Natural-killer cells and dendritic cells: "l'union fait la force". Blood
106: 2252-2258
[Abstract]
[Full Text]
-
Morandi, B., Costa, R., Falco, M., Parolini, S., De Maria, A., Ratto, G., Mingari, M. C., Melioli, G., Moretta, A., Ferlazzo, G.
(2005). Distinctive Lack of CD48 Expression in Subsets of Human Dendritic Cells Tunes NK Cell Activation. J. Immunol.
175: 3690-3697
[Abstract]
[Full Text]
-
Fauriat, C., Moretta, A., Olive, D., Costello, R. T.
(2005). Defective killing of dendritic cells by autologous natural killer cells from acute myeloid leukemia patients. Blood
106: 2186-2188
[Abstract]
[Full Text]
-
Atochina, O., Harn, D.
(2005). LNFPIII/LeX-Stimulated Macrophages Activate Natural Killer Cells via CD40-CD40L Interaction. CVI
12: 1041-1049
[Abstract]
[Full Text]
-
Massa, C., Melani, C., Colombo, M. P.
(2005). Chaperon and Adjuvant Activity of hsp70: Different Natural Killer Requirement for Cross-Priming of Chaperoned and Bystander Antigens. Cancer Res.
65: 7942-7949
[Abstract]
[Full Text]
-
Prlic, M., Gibbs, J., Jameson, S. C.
(2005). Characteristics of NK Cell Migration Early after Vaccinia Infection. J. Immunol.
175: 2152-2157
[Abstract]
[Full Text]
-
Williams, A. P., Bateman, A. R., Khakoo, S. I.
(2005). HANGING IN THE BALANCE: KIR and Their Role in Disease. Mol. Interv.
5: 226-240
[Abstract]
[Full Text]
-
Terme, M., Borg, C., Guilhot, F., Masurier, C., Flament, C., Wagner, E. F., Caillat-Zucman, S., Bernheim, A., Turhan, A. G., Caignard, A., Zitvogel, L.
(2005). BCR/ABL Promotes Dendritic Cell-Mediated Natural Killer Cell Activation. Cancer Res.
65: 6409-6417
[Abstract]
[Full Text]
-
Vitale, M., Chiesa, M. D., Carlomagno, S., Pende, D., Arico, M., Moretta, L., Moretta, A.
(2005). NK-dependent DC maturation is mediated by TNF{alpha} and IFN{gamma} released upon engagement of the NKp30 triggering receptor. Blood
106: 566-571
[Abstract]
[Full Text]
-
Semino, C., Angelini, G., Poggi, A., Rubartelli, A.
(2005). NK/iDC interaction results in IL-18 secretion by DCs at the synaptic cleft followed by NK cell activation and release of the DC maturation factor HMGB1. Blood
106: 609-616
[Abstract]
[Full Text]
-
Zanoni, I., Foti, M., Ricciardi-Castagnoli, P., Granucci, F.
(2005). TLR-Dependent Activation Stimuli Associated with Th1 Responses Confer NK Cell Stimulatory Capacity to Mouse Dendritic Cells. J. Immunol.
175: 286-292
[Abstract]
[Full Text]
-
Adam, C., King, S., Allgeier, T., Braumuller, H., Luking, C., Mysliwietz, J., Kriegeskorte, A., Busch, D. H., Rocken, M., Mocikat, R.
(2005). DC-NK cell cross talk as a novel CD4+ T-cell-independent pathway for antitumor CTL induction. Blood
106: 338-344
[Abstract]
[Full Text]
-
van Gisbergen, K. P.J.M., Sanchez-Hernandez, M., Geijtenbeek, T. B.H., van Kooyk, Y.
(2005). Neutrophils mediate immune modulation of dendritic cells through glycosylation-dependent interactions between Mac-1 and DC-SIGN. JEM
201: 1281-1292
[Abstract]
[Full Text]
-
Trivedi, P. P., Roberts, P. C., Wolf, N. A., Swanborg, R. H.
(2005). NK Cells Inhibit T Cell Proliferation via p21-Mediated Cell Cycle Arrest. J. Immunol.
174: 4590-4597
[Abstract]
[Full Text]
-
Marcenaro, E., Chiesa, M. D., Bellora, F., Parolini, S., Millo, R., Moretta, L., Moretta, A.
(2005). IL-12 or IL-4 Prime Human NK Cells to Mediate Functionally Divergent Interactions with Dendritic Cells or Tumors. J. Immunol.
174: 3992-3998
[Abstract]
[Full Text]
-
Schmitz, M., Zhao, S., Deuse, Y., Schakel, K., Wehner, R., Wohner, H., Holig, K., Wienforth, F., Kiessling, A., Bornhauser, M., Temme, A., Rieger, M. A., Weigle, B., Bachmann, M., Rieber, E. P.
(2005). Tumoricidal Potential of Native Blood Dendritic Cells: Direct Tumor Cell Killing and Activation of NK Cell-Mediated Cytotoxicity. J. Immunol.
174: 4127-4134
[Abstract]
[Full Text]
-
Makarenkova, V., Chakrabarti, A. K., Liberatore, J. A., Popovic, P., Lu, G., Watkins, S., Vujanovic, N. L.
(2005). Dendritic cells and natural killer cells interact via multiple TNF family molecules. J. Leukoc. Biol.
77: 408-413
[Abstract]
[Full Text]
-
Pillarisetty, V. G., Katz, S. C., Bleier, J. I., Shah, A. B., DeMatteo, R. P.
(2005). Natural Killer Dendritic Cells Have Both Antigen Presenting and Lytic Function and in Response to CpG Produce IFN-{gamma} via Autocrine IL-12. J. Immunol.
174: 2612-2618
[Abstract]
[Full Text]
-
Draghi, M., Yawata, N., Gleimer, M., Yawata, M., Valiante, N. M., Parham, P.
(2005). Single-cell analysis of the human NK cell response to missing self and its inhibition by HLA class I. Blood
105: 2028-2035
[Abstract]
[Full Text]
-
Gerosa, F., Gobbi, A., Zorzi, P., Burg, S., Briere, F., Carra, G., Trinchieri, G.
(2005). The Reciprocal Interaction of NK Cells with Plasmacytoid or Myeloid Dendritic Cells Profoundly Affects Innate Resistance Functions. J. Immunol.
174: 727-734
[Abstract]
[Full Text]
-
Kamath, A. T., Sheasby, C. E., Tough, D. F.
(2005). Dendritic Cells and NK Cells Stimulate Bystander T Cell Activation in Response to TLR Agonists through Secretion of IFN-{alpha}{beta} and IFN-{gamma}. J. Immunol.
174: 767-776
[Abstract]
[Full Text]
-
Conti, L., Casetti, R., Cardone, M., Varano, B., Martino, A., Belardelli, F., Poccia, F., Gessani, S.
(2005). Reciprocal Activating Interaction Between Dendritic Cells and Pamidronate-Stimulated {gamma}{delta} T Cells: Role of CD86 and Inflammatory Cytokines. J. Immunol.
174: 252-260
[Abstract]
[Full Text]
-
Munz, C., Dao, T., Ferlazzo, G., de Cos, M. A., Goodman, K., Young, J. W.
(2005). Mature myeloid dendritic cell subsets have distinct roles for activation and viability of circulating human natural killer cells. Blood
105: 266-273
[Abstract]
[Full Text]
-
Ferlazzo, G., Pack, M., Thomas, D., Paludan, C., Schmid, D., Strowig, T., Bougras, G., Muller, W. A., Moretta, L., Munz, C.
(2004). Distinct roles of IL-12 and IL-15 in human natural killer cell activation by dendritic cells from secondary lymphoid organs. Proc. Natl. Acad. Sci. USA
101: 16606-16611
[Abstract]
[Full Text]
-
Dalbeth, N., Gundle, R., Davies, R. J. O., Lee, Y. C. G., McMichael, A. J., Callan, M. F. C.
(2004). CD56bright NK Cells Are Enriched at Inflammatory Sites and Can Engage with Monocytes in a Reciprocal Program of Activation. J. Immunol.
173: 6418-6426
[Abstract]
[Full Text]
-
Borg, C., Jalil, A., Laderach, D., Maruyama, K., Wakasugi, H., Charrier, S., Ryffel, B., Cambi, A., Figdor, C., Vainchenker, W., Galy, A., Caignard, A., Zitvogel, L.
(2004). NK cell activation by dendritic cells (DCs) requires the formation of a synapse leading to IL-12 polarization in DCs. Blood
104: 3267-3275
[Abstract]
[Full Text]
-
Koka, R., Burkett, P., Chien, M., Chai, S., Boone, D. L., Ma, A.
(2004). Cutting Edge: Murine Dendritic Cells Require IL-15R{alpha} to Prime NK Cells. J. Immunol.
173: 3594-3598
[Abstract]
[Full Text]
-
Ratzinger, G., Baggers, J., de Cos, M. A., Yuan, J., Dao, T., Reagan, J. L., Munz, C., Heller, G., Young, J. W.
(2004). Mature Human Langerhans Cells Derived from CD34+ Hematopoietic Progenitors Stimulate Greater Cytolytic T Lymphocyte Activity in the Absence of Bioactive IL-12p70, by Either Single Peptide Presentation or Cross-Priming, Than Do Dermal-Interstitial or Monocyte-Derived Dendritic Cells. J. Immunol.
173: 2780-2791
[Abstract]
[Full Text]
-
Granucci, F., Zanoni, I., Pavelka, N., van Dommelen, S. L.H., Andoniou, C. E., Belardelli, F., Degli Esposti, M. A., Ricciardi-Castagnoli, P.
(2004). A Contribution of Mouse Dendritic Cell-Derived IL-2 for NK Cell Activation. JEM
200: 287-295
[Abstract]
[Full Text]
-
Setiady, Y. Y., Pramoonjago, P., Tung, K. S. K.
(2004). Requirements of NK Cells and Proinflammatory Cytokines in T Cell-Dependent Neonatal Autoimmune Ovarian Disease Triggered by Immune Complex. J. Immunol.
173: 1051-1058
[Abstract]
[Full Text]
-
Sivori, S., Falco, M., Chiesa, M. D., Carlomagno, S., Vitale, M., Moretta, L., Moretta, A.
(2004). CpG and double-stranded RNA trigger human NK cells by Toll-like receptors: Induction of cytokine release and cytotoxicity against tumors and dendritic cells. Proc. Natl. Acad. Sci. USA
101: 10116-10121
[Abstract]
[Full Text]
-
Terme, M., Tomasello, E., Maruyama, K., Crepineau, F., Chaput, N., Flament, C., Marolleau, J.-P., Angevin, E., Wagner, E. F., Salomon, B., Lemonnier, F. A., Wakasugi, H., Colonna, M., Vivier, E., Zitvogel, L.
(2004). IL-4 Confers NK Stimulatory Capacity to Murine Dendritic Cells: A Signaling Pathway Involving KARAP/DAP12-Triggering Receptor Expressed on Myeloid Cell 2 Molecules. J. Immunol.
172: 5957-5966
[Abstract]
[Full Text]
-
Lee, K.-M., McNerney, M. E., Stepp, S. E., Mathew, P. A., Schatzle, J. D., Bennett, M., Kumar, V.
(2004). 2B4 Acts As a Non-Major Histocompatibility Complex Binding Inhibitory Receptor on Mouse Natural Killer Cells. JEM
199: 1245-1254
[Abstract]
[Full Text]
-
Tosi, D., Valenti, R., Cova, A., Sovena, G., Huber, V., Pilla, L., Arienti, F., Belardelli, F., Parmiani, G., Rivoltini, L.
(2004). Role of Cross-Talk between IFN-{alpha}-Induced Monocyte-Derived Dendritic Cells and NK Cells in Priming CD8+ T Cell Responses against Human Tumor Antigens. J. Immunol.
172: 5363-5370
[Abstract]
[Full Text]
-
Ribas, A., Wargo, J. A., Comin-Anduix, B., Sanetti, S., Schumacher, L. Y., McLean, C., Dissette, V. B., Glaspy, J. A., McBride, W. H., Butterfield, L. H., Economou, J. S.
(2004). Enhanced Tumor Responses to Dendritic Cells in the Absence of CD8-Positive Cells. J. Immunol.
172: 4762-4769
[Abstract]
[Full Text]
-
Pan, P.-Y., Gu, P., Li, Q., Xu, D., Weber, K., Chen, S.-H.
(2004). Regulation of Dendritic Cell Function by NK Cells: Mechanisms Underlying the Synergism in the Combination Therapy of IL-12 and 4-1BB Activation. J. Immunol.
172: 4779-4789
[Abstract]
[Full Text]
-
Massa, C., Guiducci, C., Arioli, I., Parenza, M., Colombo, M. P., Melani, C.
(2004). Enhanced Efficacy of Tumor Cell Vaccines Transfected with Secretable hsp70. Cancer Res.
64: 1502-1508
[Abstract]
[Full Text]
-
Li, Q., Pan, P.-Y., Gu, P., Xu, D., Chen, S.-H.
(2004). Role of Immature Myeloid Gr-1+ Cells in the Development of Antitumor Immunity. Cancer Res.
64: 1130-1139
[Abstract]
[Full Text]
-
Ferlazzo, G., Munz, C.
(2004). NK Cell Compartments and Their Activation by Dendritic Cells. J. Immunol.
172: 1333-1339
[Full Text]
-
Ferlazzo, G., Thomas, D., Lin, S.-L., Goodman, K., Morandi, B., Muller, W. A., Moretta, A., Munz, C.
(2004). The Abundant NK Cells in Human Secondary Lymphoid Tissues Require Activation to Express Killer Cell Ig-Like Receptors and Become Cytolytic. J. Immunol.
172: 1455-1462
[Abstract]
[Full Text]
-
Hayakawa, Y., Screpanti, V., Yagita, H., Grandien, A., Ljunggren, H.-G., Smyth, M. J., Chambers, B. J.
(2004). NK Cell TRAIL Eliminates Immature Dendritic Cells In Vivo and Limits Dendritic Cell Vaccination Efficacy. J. Immunol.
172: 123-129
[Abstract]
[Full Text]
-
Mailliard, R. B., Son, Y.-I., Redlinger, R., Coates, P. T., Giermasz, A., Morel, P. A., Storkus, W. J., Kalinski, P.
(2003). Dendritic Cells Mediate NK Cell Help for Th1 and CTL Responses: Two-Signal Requirement for the Induction of NK Cell Helper Function. J. Immunol.
171: 2366-2373
[Abstract]
[Full Text]
-
Jin, Y., Knudsen, E., Wang, L., Bryceson, Y., Damaj, B., Gessani, S., Maghazachi, A. A.
(2003). Sphingosine 1-phosphate is a novel inhibitor of T-cell proliferation. Blood
101: 4909-4915
[Abstract]
[Full Text]
-
Fehniger, T. A., Cooper, M. A., Nuovo, G. J., Cella, M., Facchetti, F., Colonna, M., Caligiuri, M. A.
(2003). CD56bright natural killer cells are present in human lymph nodes and are activated by T cell-derived IL-2: a potential new link between adaptive and innate immunity. Blood
101: 3052-3057
[Abstract]
[Full Text]
-
Castriconi, R., Cantoni, C., Della Chiesa, M., Vitale, M., Marcenaro, E., Conte, R., Biassoni, R., Bottino, C., Moretta, L., Moretta, A.
(2003). Transforming growth factor beta 1 inhibits expression of NKp30 and NKG2D receptors: Consequences for the NK-mediated killing of dendritic cells. Proc. Natl. Acad. Sci. USA
100: 4120-4125
[Abstract]
[Full Text]
-
Zeuner, R. A., Klinman, D. M., Illei, G., Yarboro, C., Ishii, K. J., Gursel, M., Verthelyi, D.
(2003). Response of peripheral blood mononuclear cells from lupus patients to stimulation by CpG oligodeoxynucleotides. Rheumatology (Oxford)
42: 563-569
[Abstract]
[Full Text]
-
Smith, C. L, Dulphy, N., Salio, M., Cerundolo, V.
(2002). Immunotherapy of colorectal cancer. Br Med Bull
64: 181-200
[Abstract]
[Full Text]
-
Kitaichi, N., Kotake, S., Morohashi, T., Onoe, K., Ohno, S., Taylor, A. W.
(2002). Diminution of experimental autoimmune uveoretinitis (EAU) in mice depleted of NK cells. J. Leukoc. Biol.
72: 1117-1121
[Abstract]
[Full Text]
-
Valteau-Couanet, D., Leboulaire, C., Maincent, K., Tournier, M., Hartmann, O., Benard, J., Beaujean, F., Boccaccio, C., Zitvogel, L., Angevin, E.
(2002). Dendritic cells for NK/LAK activation: rationale for multicellular immunotherapy in neuroblastoma patients. Blood
100: 2554-2561
[Abstract]
[Full Text]
-
Zitvogel, L.
(2002). Dendritic and Natural Killer Cells Cooperate in the Control/Switch of Innate Immunity. JEM
195: F9-F14
[Full Text]
Top
Abstract
Introduction
) or with NK cells (
) at a ratio of 5:1 (NK/DC) in the presence of the indicated doses of LPS. The percentage of CD86bright DC was determined by specific gating. (B) The representative experiment shown was performed in the presence of 6.25 ng/ml of LPS and the iDCs were incubated alone (gray bar); with NK cells at a 5:1 (NK/DC) ratio (black bar); with NK cells (5:1) plus 10 µg/ml of a neutralizing antibody for TNF-
) or absence (
) of 6.25 ng/ml of LPS. DC maturation was determined as in A. (D) NK cells were incubated for 48 h either alone (NK) or with iDCs at the indicated ratios (NK/DC) in the presence (
